Document is current
Any future updates will be listed below
-
Authors
Nuaaman, Mais M
Pope, Janet E
-
Funding
Funding for this research was provided by:
Scleroderma Society of Ontario (2024)
Scleroderma Society of Canada
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 6 August 2025
First Online: 1 September 2025
Declarations
:
: Janet E Pope Grants/research – BMS, Janssen, Mallinckrodt, Pfizer (Seattle Genetics), Consultant – AbbVie, Amgen, Astra Zeneca, Boehringer Ingelheim, Boxer Capital, Bristol Myers Squibb, Celltrion Healthcare, Eli Lilly, Frensenius Kabi, GSK, Janssen, Merck, Mitsubishi Tanabe Pharma, Novartis, Pfizer, Sandoz, Samsung, Sanofi, Speaker/Advisory board – AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Certa, Eli Lilly, Frensenius Kabi, Janssen, Nordic Pharma, Novartis, Organon, Otsuka, Palleon, Pfizer, Sandoz, Sanofi, UCB, Zura, DSMB: Astra Zeneca, Horizon. Mais M Nuaaman declares no conflicts of interest.
